Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GRAL · against 197 other Healthcare companies of similar size
Ranked #44 of 198 · scores higher than 77% of peers
Bars: peers in each 10-point band of the growth score25 peers with a growth score of 80–89, including GRAL · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | GRAL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 198 reported | 23.1% | 8.1% | 81% | 33% | |
| Earnings per share growthHigher is better · 141 reported | Not reported | 9.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 190 reported | 38.4% | 9.0% | 89% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 8.8B USD | 99 | 31 | |
| 3 | 37.3B HKD (≈$4.8B) | 98 | 90 | |
| 3 | 3.8B USD | 98 | 71 | |
| 3 | 9.3B USD | 98 | 64 | |
| 36 | 10.7B USD | 84 | 65 | |
| 41 | 4.1B USD | 83 | 39 | |
| 41 | 4.2B USD | 83 | 41 | |
| 41 | 9.1B USD | 83 | 74 | |
| 44 | 6.2B USD | 82 | 44 | |
| 44 | 6.0B USD | 82 | 30 | |
| 44 | 4.4B USD | 82 | 66 | |
| 47 | 5.76T KRW (≈$4.1B) | 81 | 59 | |
| 47 | 379.9B INR (≈$4.6B) | 81 | 55 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score